Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 591 entries
View as:

Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03317119 Org: User:
Start: 04/11/18 End: 07/14/23 Due: 07/14/24

Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05152459 Org: User:
Start: 05/01/23 End: 12/15/24 Due: 12/15/25

Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06490159 Org: User:
Start: 10/01/18 End: 12/31/25 Due: 12/31/26

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06735690 Org: User:
Start: 08/23/25 End: 03/07/29 Due: 03/07/30

Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver

Phase: N/A Priority: Normal
NCT ID: NCT03005002 Org: User:
Start: 06/28/17 End: 11/26/19 Due: 11/26/20

Comic Art Creation as Supportive Care in Cancer Patients and Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT03067766 Org: User:
Start: 08/24/17 End: 02/08/19 Due: 02/08/20

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04887805 Org: User:
Start: 07/21/21 End: 11/05/26 Due: 11/05/27

Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04734730 Org: User:
Start: 05/04/21 End: 08/23/27 Due: 08/23/28

Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00645710 Org: User:
Start: 02/11/05 End: 02/07/18 Due: 02/07/19

Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06654622 Org: User:
Start: 04/01/23 End: 06/18/26 Due: 06/18/27

Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00641030 Org: User:
Start: 07/31/07 End: 01/31/11 Due: 01/31/12

Stage II/III Colorectal Cancer Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT06314958 Org: User:
Start: 03/15/23 End: 06/18/25 Due: 06/18/26

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Phase: N/A Priority: Normal
NCT ID: NCT00813501 Org: User:
Start: 06/30/08 End: 06/30/10 Due: 06/30/11

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05722288 Org: User:
Start: 01/20/23 End: 07/20/26 Due: 07/20/27

Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03422731 Org: User:
Start: 02/15/18 End: 11/06/25 Due: 11/06/26

Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT03902535 Org: User:
Start: 03/08/19 End: 06/17/22 Due: 06/17/23

Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00740597 Org: User:
Start: 07/31/08 End: 04/30/10 Due: 04/30/11

Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00550901 Org: User:
Start: 02/28/01 End: 07/31/07 Due: 07/31/08

Biology-Guided Radiation Therapy for the Treatment of Patients with Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06549478 Org: User:
Start: 07/26/24 End: 01/26/27 Due: 01/26/28

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04930653 Org: User:
Start: 10/19/22 End: 01/13/26 Due: 01/13/27

Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03592407 Org: User:
Start: 07/01/18 End: 04/30/20 Due: 04/30/21

Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00708604 Org: User:
Start: 08/31/05 End: 06/30/14 Due: 06/30/15

ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03402880 Org: User:
Start: 12/31/18 End: 12/31/19 Due: 12/31/20

Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00562978 Org: User:
Start: 05/16/00 End: 05/21/18 Due: 05/21/19

Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL

Phase: N/A Priority: Normal
NCT ID: NCT03016871 Org: User:
Start: 04/24/17 End: 01/30/26 Due: 01/30/27